摘要
目的 通过检测血清及胸水中可溶性Apo-1/Fas(sApo-1/Fas)的水平,探讨其对鉴别良恶性疾病的意义。方法 采用酶联免疫吸附法(ELISA)法检测50例恶性胸腔积液患者和48例结核性胸腔积液患者血清和胸水中sApo-1/Fas的含量。结果 恶性胸腔积液患者血清和胸水中sApo-1/Fas的含量分别为(16.3±2.5)μg/L、(38.6±13.5)μg/L,均明显高于结核性胸腔积液组(均P<0.05)。两组胸水/血清sApo-1/Fas比值差异有统计学意义(P<0.05)。血清sApo-1/Fas+胸水sApo-1/Fas对恶性胸腔积液诊断的敏感度为66.0%、特异度为93.8%、准确度为79.6%。结论 血清和胸水中sApo-1/Fas的测定有利于良恶性胸水的鉴别。
Objective To investigate the significance of the soluble Apo-1/Fas(sApo-1/Fas) in differentiating tuberculous and malignant pleural effusion.Methods The level of sApo-1/Fas was detected by enzyme linked immunosorbent assay(ELISA).in serum and pleural effusion of 50 cases with malignant pleural effusion and 48 cases with tuberculous pleural effusion.Results The level of sApo-1/Fas in the serum and pleural effusion of malignant pleural effusion patients were (16.3±2.5)μg/L and (38.6±13.5)μg/L,significantly higher than those of tuberculous patients with pleural effusion(all P<0.05).The difference of rates of serum and pleural effusion in malignant pleural effusion and tuberculous pleural effusion patients was significant(P<0.05).The sensitivity,specificity and accuracy of sApo-1/Fas in serum and malignant pleural effusion were 66.0% and 93.8% and 79.6%.ConclusionThe detecting of sApo-1/Fas may play some role in differentiating tuberculous and malignant pleural effusion.
出处
《中国基层医药》
CAS
2012年第15期2270-2272,共3页
Chinese Journal of Primary Medicine and Pharmacy